201 related articles for article (PubMed ID: 20077953)
1. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm.
Szyper-Kravitz M
Isr Med Assoc J; 2009 Oct; 11(10):633-4. PubMed ID: 20077953
[No Abstract] [Full Text] [Related]
2. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis.
Nádia EA; Carvalho JF; Bonfá E; Lotito AP; Silva CA
Isr Med Assoc J; 2009 Oct; 11(10):635-6. PubMed ID: 20077954
[No Abstract] [Full Text] [Related]
3. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
Ramanan AV; Schneider R
J Rheumatol; 2003 Feb; 30(2):401-3. PubMed ID: 12563702
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome after etanercept treatment.
Sandhu C; Chesney A; Piliotis E; Buckstein R; Koren S
J Rheumatol; 2007 Jan; 34(1):241-2. PubMed ID: 17216706
[No Abstract] [Full Text] [Related]
5. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases.
Tristano AG
Med Sci Monit; 2008 Mar; 14(3):RA27-36. PubMed ID: 18301366
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation syndrome induced by etanercept in a patient with systemic sclerosis.
Sterba G; Sterba Y; Stempel C; Blank J; Azor E; Gomez L
Isr Med Assoc J; 2010 Jul; 12(7):443-5. PubMed ID: 20862830
[No Abstract] [Full Text] [Related]
7. Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis.
Sawar H; Espinoza LR; Gedalia A
J Rheumatol; 2004 Mar; 31(3):623; author reply 623-4. PubMed ID: 14994420
[No Abstract] [Full Text] [Related]
8. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
Kimura Y; Pinho P; Walco G; Higgins G; Hummell D; Szer I; Henrickson M; Watcher S; Reiff A
J Rheumatol; 2005 May; 32(5):935-42. PubMed ID: 15868633
[TBL] [Abstract][Full Text] [Related]
9. Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis.
Tauber T; Daniel D; Barash J; Turetz J; Morad Y
Rheumatology (Oxford); 2005 Mar; 44(3):405. PubMed ID: 15637094
[No Abstract] [Full Text] [Related]
10. Hypersensitive joint reaction after etanercept treatment in a patient with juvenile rheumatoid arthritis.
Guo MM; Yang KD; Yu HR; Kuo HC
J Rheumatol; 2011 Mar; 38(3):577-9. PubMed ID: 21362794
[No Abstract] [Full Text] [Related]
11. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
[No Abstract] [Full Text] [Related]
12. Etanercept and warts.
Adams DR; Zaenglein AL; Hershey MS
J Drugs Dermatol; 2004; 3(6):601. PubMed ID: 15624740
[No Abstract] [Full Text] [Related]
13. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
Lai JH
J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
[No Abstract] [Full Text] [Related]
14. Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.
Peek R; Scott-Jupp R; Strike H; Clinch J; Ramanan AV
Ann Rheum Dis; 2006 Sep; 65(9):1259. PubMed ID: 16905590
[No Abstract] [Full Text] [Related]
15. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.
Bruck N; Suttorp M; Kabus M; Heubner G; Gahr M; Pessler F
J Clin Rheumatol; 2011 Jan; 17(1):23-7. PubMed ID: 21169853
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis.
Bout-Tabaku S; Rivas-Chacon R; Restrepo R
J Rheumatol; 2007 Dec; 34(12):2503-4. PubMed ID: 18061971
[No Abstract] [Full Text] [Related]
17. [Hemophagocytic syndrome occurring in polyarticular juvenile arthritis treated by salazopyrine].
Bouayed K; Brik H; Zakari A; Mikou N; Dehbi F
Arch Pediatr; 2006 Aug; 13(8):1156-7. PubMed ID: 16793243
[No Abstract] [Full Text] [Related]
18. Tuberculosis and treatment with infliximab.
Myers A; Clark J; Foster H
N Engl J Med; 2002 Feb; 346(8):623-6. PubMed ID: 11859881
[No Abstract] [Full Text] [Related]
19. What's new in the diagnosis and treatment of juvenile rheumatoid arthritis.
Sherry DD
J Pediatr Orthop; 2000; 20(4):419-20. PubMed ID: 10912594
[No Abstract] [Full Text] [Related]
20. Etanercept for therapy-resistant macrophage activation syndrome.
Makay B; Yilmaz S; Türkyilmaz Z; Unal N; Oren H; Unsal E
Pediatr Blood Cancer; 2008 Feb; 50(2):419-21. PubMed ID: 16900487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
